• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

减瘤手术及热灌注化疗后的并发症——我们能否做得更好？

Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better?

作者信息

Alberto V Miguel E, Zuluaga Daniela, Winter Axel, Pratschke Johann, Rau Beate, Gül Safak

机构信息

Surgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

J Surg Oncol. 2024 Nov;130(6):1403-1421. doi: 10.1002/jso.27988. Epub 2024 Nov 18.

DOI:10.1002/jso.27988
PMID:39558543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11826034/
Abstract

The main aim of this review is to analyze postoperative complications after cytoreductive surgery and intraperitoneal chemotherapy. Although the literature in this field is ever growing, reporting on complication is not a given. Nevertheless, some main risk factors such as prior surgery, high tumor burden and the center's expertize have an impact on patient outcomes. Transparency is key, if we want to continue to improve.

摘要

本综述的主要目的是分析肿瘤细胞减灭术和腹腔内化疗后的术后并发症。尽管该领域的文献不断增加，但关于并发症的报道并非必然。然而，一些主要风险因素，如既往手术史、高肿瘤负荷和中心的专业水平，会对患者的预后产生影响。如果我们想持续改进，透明度是关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144a/11826034/49d61f287cd0/JSO-130-1403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144a/11826034/49d61f287cd0/JSO-130-1403-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/144a/11826034/49d61f287cd0/JSO-130-1403-g001.jpg

相似文献

1
Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better?减瘤手术及热灌注化疗后的并发症——我们能否做得更好？
J Surg Oncol. 2024 Nov;130(6):1403-1421. doi: 10.1002/jso.27988. Epub 2024 Nov 18.
2
Impact of Perfusate Glucose Concentration on Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.灌洗液葡萄糖浓度对细胞减灭术和腹腔热灌注化疗患者围手术期结局的影响。
J Surg Res. 2020 Dec;256:206-211. doi: 10.1016/j.jss.2020.06.055. Epub 2020 Jul 22.
3
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study.细胞减灭术联合腹腔内热灌注化疗与单纯细胞减灭术治疗伴腹膜转移的肝内胆管细胞癌：一项回顾性队列研究。
Eur J Surg Oncol. 2021 Sep;47(9):2363-2368. doi: 10.1016/j.ejso.2021.05.014. Epub 2021 May 14.
4
High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.结直肠癌腹膜转移患者行细胞减灭术和腹腔热灌注化疗后，高等级术后并发症影响生存结局。
BMC Cancer. 2021 Jan 7;21(1):41. doi: 10.1186/s12885-020-07756-7.
5
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.基于腹膜癌指数（PCI）的患者选择策略用于胃癌伴腹膜转移行完全细胞减灭术加腹腔热灌注化疗：一项单中心回顾性分析 125 例患者。
Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1.
6
Risk factors for postoperative complications in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: A meta-analysis and systematic review.行细胞减灭术联合腹腔热灌注化疗患者术后并发症的危险因素：荟萃分析和系统评价。
Int J Colorectal Dis. 2024 Oct 18;39(1):167. doi: 10.1007/s00384-024-04741-5.
7
Survival and complications of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients: a systematic review and meta-analysis.老年患者细胞减灭术和腹腔内热化疗的生存和并发症：系统评价和荟萃分析。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5330-5348. doi: 10.26355/eurrev_202109_26640.
8
Short-term outcomes in older patients with peritoneal malignancy treated with cytoreductive surgery and HIPEC: Experience with 245 patients from a national centre.老年腹膜恶性肿瘤患者行细胞减灭术和 HIPEC 治疗的短期疗效：来自国家中心的 245 例患者的经验。
Eur J Surg Oncol. 2021 Sep;47(9):2358-2362. doi: 10.1016/j.ejso.2021.04.004. Epub 2021 Apr 14.
9
Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis.术前免疫营养对细胞减灭术和 HIPEC 后腹膜转移患者术后主要并发症的影响。
Nutrients. 2021 Jun 23;13(7):2147. doi: 10.3390/nu13072147.
10
Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis- causes and implication on outcomes in a population-based study.减瘤手术联合腹腔内热化疗治疗结直肠癌肝转移术后白细胞减少症——一项基于人群研究中的病因及对预后的影响
World J Surg Oncol. 2025 Apr 29;23(1):173. doi: 10.1186/s12957-025-03821-2.

引用本文的文献

1
Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors.细胞减灭术（CS）联合腹腔内热化疗（HIPEC）：术后进展、不良结局及围手术期危险因素
Healthcare (Basel). 2025 Apr 3;13(7):808. doi: 10.3390/healthcare13070808.
2
Evaluating the Impact of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Interval and Secondary Debulking in Ovarian Cancer: A Systematic Review.评估腹腔热灌注化疗（HIPEC）对卵巢癌无瘤间期和二次肿瘤细胞减灭术的影响：一项系统评价
Cancers (Basel). 2025 Mar 6;17(5):904. doi: 10.3390/cancers17050904.

本文引用的文献

1
Analysis of risk factors for major post-operative complications following intraperitoneal hyperthermic perfusion for pseudomyxoma peritonei: A retrospective cohort study.腹膜假黏液瘤腹腔热灌注术后主要并发症的危险因素分析：一项回顾性队列研究。
J Minim Access Surg. 2025 Apr 1;21(2):112-118. doi: 10.4103/jmas.jmas_299_23. Epub 2024 Mar 28.
2
Initial Experience Using Laparoscopic HIPEC for Gastric Cancer with Peritoneal Metastasis: Safety and Outcomes.腹腔镜 HIPEC 治疗胃癌合并腹膜转移的初步经验：安全性和结果。
Ann Surg Oncol. 2024 Jun;31(6):3750-3757. doi: 10.1245/s10434-024-15102-5. Epub 2024 Mar 2.
3
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer.
胃癌腹膜癌患者细胞减灭术、胃切除术及术中腹腔热灌注化疗的2期试验更新分析
Ann Surg Oncol. 2024 May;31(5):2824-2825. doi: 10.1245/s10434-024-14953-2. Epub 2024 Jan 29.
4
Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence.联合肝脏切除、细胞减灭术和腹腔内热灌注化疗治疗转移性结直肠癌：早期复发的预测因素。
Ann Surg Oncol. 2024 Apr;31(4):2378-2390. doi: 10.1245/s10434-023-14840-2. Epub 2024 Jan 3.
5
Gastric cancer with peritoneal metastases: a single center outline and comparison of different surgical and intraperitoneal treatments.胃癌伴腹膜转移：单中心概述及不同手术和腹腔内治疗的比较。
Langenbecks Arch Surg. 2023 Nov 16;408(1):437. doi: 10.1007/s00423-023-03163-1.
6
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.腹腔内热灌注化疗对胃癌合并腹膜转移患者细胞减灭术的影响：GASTRIPEC-I 期临床试验。
J Clin Oncol. 2024 Jan 10;42(2):146-156. doi: 10.1200/JCO.22.02867. Epub 2023 Oct 31.
7
Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis.腹腔热灌注紫杉醇和顺铂联合细胞减灭术治疗胃癌合并腹膜转移
Ann Surg Oncol. 2024 Jan;31(1):622-629. doi: 10.1245/s10434-023-14379-2. Epub 2023 Oct 26.
8
Prognostic Analysis of Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer: a Propensity Score-Matched Analysis.进展期胃癌预防性腹腔内热化疗的预后分析：一项倾向评分匹配分析
J Gastrointest Surg. 2023 Nov;27(11):2297-2307. doi: 10.1007/s11605-023-05823-5. Epub 2023 Sep 15.
9
Peritoneal Mesothelioma: Systematic Review of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocol Outcomes.腹膜间皮瘤：热灌注化疗（HIPEC）方案疗效的系统评价
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):39-59. doi: 10.1007/s13193-023-01728-6. Epub 2023 Mar 4.
10
Total abdominal colectomy to facilitate complete cytoreduction in 56 patients with mucinous appendiceal neoplasms with peritoneal metastases.对56例伴有腹膜转移的黏液性阑尾肿瘤患者行全腹结肠切除术以促进完全细胞减灭。
J Surg Oncol. 2023 May;127(6):1011-1018. doi: 10.1002/jso.27211. Epub 2023 Feb 13.